| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 51.77M | 76.07M | 65.54M | 91.01M | 50.97M |
| Gross Profit | 23.24M | 24.29M | 19.44M | 30.77M | 21.57M |
| EBITDA | -20.97M | -34.37M | -43.61M | -21.85M | -18.29M |
| Net Income | -25.78M | -39.66M | -50.33M | -25.34M | -25.22M |
Balance Sheet | |||||
| Total Assets | 186.73M | 104.28M | 72.43M | 105.13M | 99.68M |
| Cash, Cash Equivalents and Short-Term Investments | 146.49M | 60.98M | 27.32M | 25.92M | 65.05M |
| Total Debt | 771.00K | 966.00K | 1.02M | 0.00 | 0.00 |
| Total Liabilities | 16.94M | 18.53M | 13.30M | 16.12M | 7.38M |
| Stockholders Equity | 169.79M | 85.75M | 59.13M | 89.01M | 92.30M |
Cash Flow | |||||
| Free Cash Flow | -19.43M | -25.16M | -29.98M | -57.50M | -39.23M |
| Operating Cash Flow | -15.58M | -21.43M | -26.96M | -52.88M | -34.64M |
| Investing Cash Flow | -4.85M | -3.73M | -3.02M | -4.62M | -4.59M |
| Financing Cash Flow | 105.90M | 58.84M | 31.77M | 18.20M | 94.06M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Neutral | $60.69B | 29.62 | 21.19% | 1.79% | -6.81% | -23.16% | |
68 Neutral | $4.80B | -54.90 | -8.00% | ― | 47.10% | 64.29% | |
63 Neutral | $9.02B | 19.56 | 7.89% | 4.37% | -2.18% | -16.84% | |
62 Neutral | $40.65B | -162.51 | -2.85% | 2.79% | -23.36% | -131.15% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | $610.56M | -17.84 | ― | ― | ― | ― | |
55 Neutral | $13.10B | -243.74 | -4.42% | ― | 32.58% | -173.04% |
Effective January 5, 2026, Ambiq Micro, Inc. expanded its board of directors from six to seven members and appointed leadership expert Dr. Bernard B. Banks as a Class III director, with a term running until the 2028 annual meeting of stockholders, and as a member of the board’s Audit Committee. Banks, currently Director of Rice University’s Doerr Institute for New Leaders and a former U.S. Army Brigadier General with extensive academic and leadership credentials, will receive standard non‑employee director compensation, has entered into the same form of indemnification agreement as existing directors, and joins the board without any family ties, appointment arrangements, or related‑party transactions with the company.
The most recent analyst rating on (AMBQ) stock is a Hold with a $32.00 price target. To see the full list of analyst forecasts on Ambiq Micro, Inc. stock, see the AMBQ Stock Forecast page.